Corporate Event

Flex LNG CFO Presents at Pareto Energy Conference in Oslo

Hamilton – October 27, 2026 -- Flex LNG Ltd (NYSE: FLNG) is presenting at Pareto Securities' 33rd Annual Energy Conference in Oslo today, with Chief Financial Officer Knut Traaholt delivering the presentation.

Flex LNG operates 13 LNG carriers with two-stroke propulsion

The Bermuda-based shipping company runs thirteen LNG carriers on the water. All vessels use latest-generation two-stroke propulsion, in MEGI and X-DF configurations.

Flex LNG says these engines deliver significant improvements in fuel efficiency, and therefore a lower carbon footprint, compared with older steam and four-stroke propelled ships.

Flex LNG publishes the presentation on its website

The company has attached the presentation to its announcement and posted it on its corporate website. Investor inquiries go to Traaholt in his role as CFO of Flex LNG Management AS.

REGENXBIO Sets Oct. 20 Investor Event Before Wet AMD Pivotal Data

Image
REGENXBIO Sets Oct. 20 Investor Event Before Wet AMD Pivotal Data

Rockville, Md. – October 12, 2026 -- REGENXBIO Inc. (Nasdaq: RGNX) will host a three-hour investor event on October 20, 2026 to review its wet age-related macular degeneration (wet AMD) gene therapy program, with topline pivotal data anticipated in the fourth quarter of 2026.

Event runs 1:00 p.m. to 4:00 p.m. ET in New York and online

The session will be held in person in New York and streamed by webcast. It will cover the clinical program for surabgene lomparvovec (sura-vec, ABBV-RGX-314), which REGENXBIO is developing in collaboration with AbbVie.

Management and five retina specialists to address commercial readiness

REGENXBIO management and retina specialists will discuss the treatment landscape, unmet need, the ATMOSPHERE and ASCENT pivotal trials, and the commercial readiness of sura-vec in wet AMD.

Five key opinion leaders are scheduled to appear: